Q&A: Re-review opt-out and painless publishing by Miranda Robertson
Why yet another editorial on painless publishing 
and re-review opt-out?
To summarize succinctly in one place all the issues, some 
quite contentious, that we are aware of in the light of four 
years’ experience with re-review opt-out (originally des-
cribed in [1] and revisited in [2,3]).
What exactly is re-review opt-out - briefly?
It’s an editorial policy. Any author whose research paper 
is judged by referees to be publishable in BMC Biology 
subject to important revisions  - which may mean the 
collection of additional experimental data - will be asked 
to choose whether he or she wishes the paper to be seen 
again by the reviewers after revision.
What motivated the policy?
Starting with a letter to Science in 2008 [4], there has 
been a succession of complaints about the frustrations 
and in some cases quite serious problems engendered by 
the increasingly protracted and iterative reviewing 
practices of, in particular, the higher-profile journals (for 
example, [5-7]). One of our Editorial Board members 
suffered a particularly egregious example and appealed to 
us for help (his story will be published shortly as a podcast), 
and the policy was launched as a direct consequence.
We (at that time, Journal of Biology  - the fusion with 
BMC Biology came after the policy was established) 
decided to operate, for an experimental period, a policy 
whereby in the case of important but non-lethal 
criticisms by referees, authors would be asked to address 
the issues raised, and then to choose whether the referees 
saw the paper again or not.
Don’t you run the risk of publishing invalid papers? 
Any journal does that, under any system of review: no 
system is perfect. The question is whether ultimately it is 
the editors’ responsibility to ensure the soundness of the 
published paper, or the authors’. Re-review opt-out places 
the onus on the authors. Is that likely to result in the 
publication of more invalid papers than under other 
systems? We think not.
Really? Surely insistence on satisfying referees 
must reduce the risk of publishing invalid papers?
In principle, yes. In practice, first of all, when authors opt 
out of re-review their revised manuscripts are scrutinized 
by the editorial team, and may be rejected if it seems 
clear that the problems identified by the referees have not 
been addressed. Second, don’t forget, authors can opt in 
to re-review - and about half of them do. (Sometimes an 
author will say he/she would prefer the referees to see the 
paper again, but wants to avoid the delay to publication, 
and in those cases we ask the referees if they will return 
reports within a week, and proceed without their input if 
they don’t.)
Third, iterative re-review is exhausting for referees, and 
after two or three iterations where authors have revised 
inadequately, the referees can simply lose patience and 
recommend publication. We think it unlikely that 
significantly more inadequately supported papers will be 
published under re-review opt-out than under the more 
usual system; and it will have the substantial advantage of 
lessening the burden on a limited pool of referees.
What about the referees? Surely they are likely to 
be unwilling to assess papers if they think their 
criticisms may be ignored?
We were afraid of this. We do state of course in our 
invitation to referees that authors will be offered a choice 
about whether their revisions are seen by their reviewers. 
In practice, we have almost never had a referee refuse to 
assess a paper for that reason.
And it is not the case that their criticisms may be 
ignored: as already stated, if the authors opt out of re-
review, the editors look carefully to see if important 
criticisms seem to have been addressed, and the paper 
may be rejected if the response seems inadequate  - for 
example, if the authors have argued that additional data 
requested by the referees are unnecessary, or if it seems 
that additional evidence provided is not persuasive.
If the editors decide to reject the paper, can the 
authors change their mind and appeal to the 
referees?
Yes. This occasionally happens, and in those cases the 
referees sometimes advise on balance that the paper 
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should be published. It is not always straightforward to 
decide how much evidence should be required.
Do you allow authors to choose to go back to some 
referees but not all of them?
No. It is not uncommon for (say) two out of three 
reviewers to make positive recommendations, while a 
third has criticisms that seem to need to be addressed, 
and authors do sometimes in those cases argue that the 
third referee is mistaken and should be disregarded.
In a case like that, we consult all three referees, but we 
send each referee all the comments on the original 
version of the paper, along with the authors’ responses, 
and ask the favorable referees to comment on the 
criticisms of the unfavorable one. We may also seek 
adjudication from a fourth reviewer or an Editorial Board 
member, if the authors request it, or there is no consensus 
among the existing referees.
You are a general biology journal with a policy 
of selecting papers of some general interest 
or importance - is it part of the referee’s job to 
evaluate that?
No. All submissions to BMC Biology are screened first for 
suitability on grounds of their interest or importance in 
principle for the journal  - usually by an Editorial Board 
member, sometimes (if there is no appropriate Editorial 
Board member, or none is available) by an appropriate 
expert not on our Board. Only if the paper is judged 
suitable on this first screen is it sent to referees, and the 
referees are then asked to evaluate the paper solely on the 
basis of its technical soundness and not on the basis of its 
interest.
But surely referees may be more expert, or may 
look at the paper more closely, than your editorial 
Board members, and have a different view of its 
claims to special interest or importance?
Usually, the Editorial Board member is judging the 
paper’s claim at face value and on the basis of his or her 
expert general perspective rather than examining the 
paper in detail, and giving an opinion on that basis. Of 
course it is just an opinion, and opinions vary - it is in the 
nature of a selective journal that it must draw lines on a 
continuum from highly specialized to extremely inter-
esting and/or important to all biologists. In the absence 
of expert consensus, it is the editors’ decision where the 
line should be drawn. BMC Biology is usually generous.
Because it is not the Editorial Board member’s job, 
however, to evaluate the technical soundness of sub-
missions, it is not uncommon for referees to report that 
although the claim of a paper is interesting, it is 
overstated in the light of detailed scrutiny of the data. In 
such a case, the paper may contain perfectly valid data 
supporting a point of relatively specialized interest, but 
inadequate data in support of its more striking 
conclusions.
So in those cases, you reject the paper?
Yes and no. Usually, we offer authors the option of 
extending their paper to bolster its more interesting 
claim, or resubmitting to one of our subject-specific 
sister journals, which (in the case that the paper is 
otherwise completely sound) may simply publish it on 
the basis of the existing referees’ advice. Depending 
upon how much work we think would be involved in 
support ing the authors’ more striking claim, we may 
either reject the paper but encourage resubmission to a 
sister journal (with the option of resubmission to us if 
they think they can provide the necessary data), or we 
may invite revision for BMC Biology but with the 
proviso that the revised paper may seem more 
appropriate for a sister journal.
If the paper is resubmitted to a subject-specific 
sister journal in the BioMed Central series, will 
fresh referees be consulted?
Normally a decision can be made on the basis of the 
reports sent to BMC Biology. The entire file on the paper 
can be made available to the sister journal, so that in 
some cases the paper can simply be accepted as it stands 
in a sister journal; in others, authors may need to revise 
the paper to meet criticisms other than those bearing on 
the disputed point of general interest.
Isn’t the issue of how well a claim needs to be 
supported also a judgment call?
Yes. We have already acknowledged this above. In 
straightforward cases where a paper is reporting a 
significant step in an established field with well validated 
technology, it is likely to be relatively simple to say how 
well the conclusions should be supported by the data.
It is not so easy in fields where the data are by their 
nature fragmentary or hard to interpret (phylogenetic 
data come to mind, whether fossil or genomic); and it is 
also less easy where new ground is being broken (see the 
comment on the discovery of cyclins in [1]). If we turned 
away all papers whose conclusions were not solidly 
grounded in impeccable data, we should risk becoming a 
very dull journal. Part of our aim is to provide a platform 
for papers that may be contentious for one reason or 
another: they make people think.
are you saying all impeccable papers are dull?
Certainly not. Only that a paper doesn’t have to be 
impeccable to be important, and we shouldn’t expect 
papers breaking new ground to have every i dotted and t 
crossed (to mix metaphors).
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So are you saying you publish papers that may be 
wrong just to be provocative?
No. It would be irresponsible to publish flimsy papers 
just to provoke. Papers that make claims that are open to 
question, or provocative, should be well supported within 
the bounds of what is possible or reasonable, or should at 
least make it clear where evidence ends and speculation 
begins.
But surely you are misleading your nonspecialist 
readers if you publish such questionable papers?
That is a risk. So when we do publish papers that require 
some qualification not provided in the paper itself, we 
commission expert commentary to put the paper in 
perspective.
So the authors can say what they like about their 
data, no matter how outrageous?
No. We do think that what is in a paper is ultimately the 
responsibility of the author. But it is the responsibility of 
the editor to decide (on the basis of expert advice from 
referees) what should be published. We may err on the 
side of publishing an author’s interpretation even if not 
fully endorsed by referees, provided that the authors 
clearly state that it is what they propose, and not that it is 
compelled by the evidence. But we should not publish a 
paper making a claim that is flatly wrong - either on the 
basis of evidence in the paper, or on the basis of others’ 
evidence. Nor should we publish misrepresentation of 
others’ work. In such cases, publication  - provided that 
the paper is otherwise sound and interesting enough for 
BMC Biology  - would be contingent on the authors’ 
modifying their text appropriately.
Do you think you have answered all the questions 
arising from this policy?
Almost certainly not: please send us yours.
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